Medscape Conference Coverage, based on selected sessions at:

The Liver Meeting 2008: 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD)

October 31 - November 04, 2008; San Francisco, California

This activity is not sanctioned by, nor a part of, the American Association for the Study of Liver Diseases. Conference news does not receive grant support and is produced independently.

Conference News

  • Promising Results for Hepatitis C

    The addition of boceprevir or telaprevir improved the sustained virologic response rate about 20% to 40%.
    Medscape Medical News, November 6, 2008
  • Biomarkers May Guide Sorafenib Treatment

    An analysis of 602 patients with hepatocellular carcinoma used 7 plasma and tumor biomarkers to predict time to progression with and without sorafenib.
    Medscape Medical News, November 5, 2008
  • Mortality Lower for Early Liver Transplant

    Even high-donor-risk index organs reduce mortality for patients with MELD scores of 11 to 24 if liver transplantation is done early.
    Medscape Medical News, November 3, 2008
Disclaimer

The materials presented here do not reflect the views of Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Association for the Study of Liver Diseases. These materials and the related activity are not sanctioned by the American Association for the Study of Liver Diseases or the commercial supporter of the conference and do not constitute an official part of that conference.